Eiki Ichihara

24PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 25, 2026
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment.

|Jun 02, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.

|Feb 27, 2026
TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung Cancer.

Tadahiro Kuribayashi, Jun Nishimura, Sachi Okawa

|Dec 01, 2025
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.

Pascale Tomasini, Yongsheng Wang, Yongsheng Li

|Oct 21, 2025
Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case report.

Miho Fujiwara, Kiichiro Ninomiya, Emi Chikuie

|Aug 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy.

Nobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama

Pageof 4

Frequent Collaborators

7 joint publications

Kadoaki Ohashi

6 joint publications

Hirohisa Kano

6 joint publications

Katuyuki Hotta

5 joint publications

Go Makimoto